Bernstein Harold
SEC CIK 2050172 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MAZE | Maze Therapeutics, Inc. | Pres, CMO, R, D | 0 | — | $9.02M | 26 | 2025-12-29 | 2026-09-04 |
Most active insiders at MAZE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Bernstein Harold | Pres, CMO, R, D | — | $9.02M |
| 2 | Coloma Jason V | CEO, Dir | — | $5.25M |
| 3 | Dandekar Atul | CSBO | — | $5.01M |
| 4 | Bachrodt Amy | SVP, Fin | — | $1.56M |
| 5 | Sohn Catherine A. | Dir | — | $1.15M |
| 6 | Courtney Phillips | GC, Corp. Sec | — | $104.8K |
| 7 | Third Rock Ventures GP V, LP | 10% | — | — |
| 8 | HOMCY CHARLES J | Dir | — | — |
Transactions 26
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-08 16:20 | 2026-09-04 | MAZE | Maze Therapeutics, Inc. | Bernstein Harold | Pres, CMO, R, D | S - Sale | $26.22 | -9,705 | 0 | -100% | -$254.5K |
| M | 2026-09-04 16:22 | 2026-09-02+ | MAZE | Maze Therapeutics, Inc. | Bernstein Harold | Pres, CMO, R, D | S - Sale | $26.24 | -10.3K | 9,705 | -51% | -$270.1K |
| DMT | 2026-09-03 16:24 | 2026-09-01 | MAZE | Maze Therapeutics, Inc. | Bernstein Harold | Pres, CMO, R, D | M - OptEx | $4.65 | +36.1K | 20.0K | New | +$168.2K |
| DT | 2026-09-03 16:24 | 2026-09-01 | MAZE | Maze Therapeutics, Inc. | Bernstein Harold | Pres, CMO, R, D | S - Sale+OE | $26.36 | -16.1K | 0 | -100% | -$425.5K |
| DT | 2026-08-14 16:54 | 2026-08-13 | MAZE | Maze Therapeutics, Inc. | Bernstein Harold | Pres, CMO, R, D | M - OptEx | $10.42 | +16.1K | 16.1K | New | +$168.2K |
| DT | 2026-08-14 16:54 | 2026-08-13 | MAZE | Maze Therapeutics, Inc. | Bernstein Harold | Pres, CMO, R, D | S - Sale+OE | $27.61 | -16.1K | 0 | -100% | -$445.6K |
| DT | 2026-07-02 16:29 | 2026-07-01 | MAZE | Maze Therapeutics, Inc. | Bernstein Harold | Pres, CMO, R, D | M - OptEx | $10.42 | +14.6K | 14.6K | New | +$152.2K |
| DMT | 2026-07-02 16:29 | 2026-07-01 | MAZE | Maze Therapeutics, Inc. | Bernstein Harold | Pres, CMO, R, D | S - Sale+OE | $29.90 | -14.6K | 0 | -100% | -$436.9K |
| DT | 2026-06-03 17:01 | 2026-06-01 | MAZE | Maze Therapeutics, Inc. | Bernstein Harold | Pres, CMO, R, D | M - OptEx | $10.42 | +14.9K | 14.9K | New | +$154.8K |
| DMT | 2026-06-03 17:01 | 2026-06-01 | MAZE | Maze Therapeutics, Inc. | Bernstein Harold | Pres, CMO, R, D | S - Sale+OE | $25.66 | -14.9K | 0 | -100% | -$381.1K |
| DT | 2026-05-18 17:03 | 2026-05-14 | MAZE | Maze Therapeutics, Inc. | Bernstein Harold | Pres, CMO, R, D | M - OptEx | $10.42 | +15.0K | 15.0K | New | +$156.3K |
| DT | 2026-05-18 17:03 | 2026-05-14 | MAZE | Maze Therapeutics, Inc. | Bernstein Harold | Pres, CMO, R, D | S - Sale+OE | $26.22 | -15.0K | 0 | -100% | -$393.4K |
| DT | 2026-04-02 16:08 | 2026-04-01 | MAZE | Maze Therapeutics, Inc. | Bernstein Harold | Pres, CMO, R, D | M - OptEx | $10.42 | +15.0K | 15.0K | New | +$156.3K |
| DMT | 2026-04-02 16:08 | 2026-04-01 | MAZE | Maze Therapeutics, Inc. | Bernstein Harold | Pres, CMO, R, D | S - Sale+OE | $29.46 | -15.0K | 0 | -100% | -$441.9K |
| DM | 2026-03-20 | 2026-03-20 | MAZE | Maze Therapeutics, Inc. | Bernstein Harold | Pres, CMO, R, D | S - Sale+OE | $49.10 | -15.0K | 0 | -100% | -$736.4K |
| D | 2026-03-20 | 2026-03-20 | MAZE | Maze Therapeutics, Inc. | Bernstein Harold | Pres, CMO, R, D | M - OptEx | $10.42 | +15.0K | 15.0K | New | +$156.3K |
| D | 2026-03-12 | 2026-03-10 | MAZE | Maze Therapeutics, Inc. | Bernstein Harold | Pres, CMO, R, D | M - OptEx | $10.42 | +30.0K | 30.0K | New | +$312.6K |
| DM | 2026-03-12 | 2026-03-10 | MAZE | Maze Therapeutics, Inc. | Bernstein Harold | Pres, CMO, R, D | S - Sale+OE | $50.46 | -30.0K | 348 | -99% | -$1.51M |
| D | 2026-02-04 | 2026-02-02 | MAZE | Maze Therapeutics, Inc. | Bernstein Harold | Pres, CMO, R, D | M - OptEx | $10.42 | +15.0K | 15.0K | New | +$156.3K |
| DM | 2026-02-04 | 2026-02-02 | MAZE | Maze Therapeutics, Inc. | Bernstein Harold | Pres, CMO, R, D | S - Sale+OE | $46.02 | -15.0K | 100 | -99% | -$690.3K |
| D | 2026-01-09 | 2026-01-07 | MAZE | Maze Therapeutics, Inc. | Bernstein Harold | Pres, CMO, R, D | M - OptEx | $10.42 | +25.2K | 25.2K | New | +$262.1K |
| D | 2026-01-09 | 2026-01-07 | MAZE | Maze Therapeutics, Inc. | Bernstein Harold | Pres, CMO, R, D | S - Sale+OE | $40.20 | -25.2K | 0 | -100% | -$1.01M |
| DM | 2026-01-06 | 2026-01-02+ | MAZE | Maze Therapeutics, Inc. | Bernstein Harold | Pres, CMO, R, D | M - OptEx | $10.42 | +4,844 | 4,432 | New | +$50.5K |
| DM | 2026-01-06 | 2026-01-02+ | MAZE | Maze Therapeutics, Inc. | Bernstein Harold | Pres, CMO, R, D | S - Sale+OE | $40.39 | -4,844 | 0 | -100% | -$195.7K |
| DM | 2025-12-31 | 2025-12-29 | MAZE | Maze Therapeutics, Inc. | Bernstein Harold | Pres, CMO, R, D | S - Sale+OE | $40.57 | -45.0K | 17.2K | -72% | -$1.83M |
| D | 2025-12-31 | 2025-12-29 | MAZE | Maze Therapeutics, Inc. | Bernstein Harold | Pres, CMO, R, D | M - OptEx | $10.42 | +45.0K | 45.0K | New | +$468.9K |
Purchase Sale Sale after option exercise All abbreviations